During the past decade, Hospital Paulistano conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 1 clinical trials were completed, i.e. on average, 9.1% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Paulistano" #1 sponsor was "Janssen Research & Development, LLC" with 5 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored, "Hospital Moinhos de Vento" with 1 trials sponsored and "Hospital do Coracao" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Paulistano" #1 collaborator was "Astellas Pharma Europe Ltd." with 1 trials as a collaborator, "Bactiguard AB" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Canadian Urologic Oncology Group" with 1 trials as a collaborator and "Cancer Trials Ireland" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Paulistano" are "Brain Death" (1 trials), "Breast Cancer" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Critically Ill" (1 trials) and "Leukemia, Myelomonocytic, Chronic" (1 trials). Many other conditions were trialed in "Hospital Paulistano" in a lesser frequency.

Most popular intervention types in "Hospital Paulistano" are "Drug" (8 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Daratumumab" (2 trials), "Dexamethasone" (2 trials), "Pomalidomide" (2 trials), "5-Fluorouracil" (1 trials) and "Amivantamab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Paulistano" are 10 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Paulistano". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Hospital Paulistano, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Paulistano, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".